Drug Shortage Report for OMEP
Report ID | 39575 |
Drug Identification Number | 02438968 |
Brand name | OMEP |
Common or Proper name | OMEP |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | BLISTERS 14S |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-01-10 |
Estimated end date | 2018-03-23 |
Actual end date | 2018-03-23 |
Shortage status | Resolved |
Updated date | 2018-03-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-03-24 | English | Compare |
v4 | 2018-03-23 | French | Compare |
v3 | 2018-03-23 | English | Compare |
v2 | 2018-02-12 | French | Compare |
v1 | 2018-02-12 | English | Compare |
Showing 1 to 5 of 5